Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Drug treatments for managing cystic fibrosis-related diabetes.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD004730. doi: 10.1002/14651858.CD004730.pub5.
Cochrane Database Syst Rev. 2020.
PMID: 33075159
Free PMC article.
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related diabetes (CFRD) has been diagnosed. ...MAIN RESULTS: The searches identified 29 trials (45 references). Four included trials provide results: …
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related di …
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM, Stolfi A.
Onady GM, et al.
Cochrane Database Syst Rev. 2016 Apr 18;4:CD004730. doi: 10.1002/14651858.CD004730.pub4.
Cochrane Database Syst Rev. 2016.
PMID: 27087121
Updated.
Review.
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related diabetes has been diagnosed. ...MAIN RESULTS: The searches identified 22 trials (34 references). Four trials (200 participants) are included: …
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related di …
Item in Clipboard
Insulin and oral agents for managing cystic fibrosis-related diabetes.
Onady GM, Stolfi A.
Onady GM, et al.
Cochrane Database Syst Rev. 2013 Jul 26;(7):CD004730. doi: 10.1002/14651858.CD004730.pub3.
Cochrane Database Syst Rev. 2013.
PMID: 23893261
Updated.
Review.
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related diabetes has been diagnosed. ...The long-term trial of insulin and repaglinide demonstrated no significant difference between treatment …
BACKGROUND: The Cystic Fibrosis Foundation recommends both short-term and long-acting insulin therapy when cystic fibrosis-related di …
Item in Clipboard
Cite
Cite